Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study
Authors
Keywords
-
Journal
LANCET INFECTIOUS DISEASES
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-12-13
DOI
10.1016/s1473-3099(22)00732-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines
- (2022) Nick Andrews et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of Covid-19 Vaccines over a 9-Month Period in North Carolina
- (2022) Dan-Yu Lin et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys
- (2022) Marc Chadeau-Hyam et al. Lancet Respiratory Medicine
- COVID-19 vaccines: Considering sex differences in efficacy and safety
- (2022) Adelaide Jensen et al. Contemporary Clinical Trials
- COVID‐19 vaccination status and testing rates in Finland—A potential cause for bias in observational vaccine effectiveness analysis
- (2022) Ilari Kuitunen et al. Influenza and Other Respiratory Viruses
- Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance
- (2022) Katherine E. Fleming-Dutra et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design
- (2022) Aziz Sheikh et al. LANCET INFECTIOUS DISEASES
- COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England
- (2022) Freja C M Kirsebom et al. LANCET INFECTIOUS DISEASES
- Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2
- (2022) Olha Puhach et al. NATURE MEDICINE
- Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
- (2022) Nick Andrews et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar
- (2022) Laith J. Abu-Raddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extended reporting guidance for vaccine effectiveness studies for variants of concern for COVID-19
- (2022) Lori-Ann Linkins et al. VACCINE
- Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar
- (2022) Hiam Chemaitelly et al. Nature Communications
- Waning effectiveness of SARS-CoV-2 mRNA vaccines in older adults: a rapid review
- (2022) Etsuro Nanishi et al. Human Vaccines & Immunotherapeutics
- Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022
- (2022) Mark W. Tenforde et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals
- (2022) Jiwon Jung et al. JAMA Network Open
- Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status
- (2022) Zachary J. Madewell et al. JAMA Network Open
- Duration of effectiveness of vaccination against COVID-19 caused by the omicron variant
- (2022) Melissa M Higdon et al. LANCET INFECTIOUS DISEASES
- Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study
- (2022) Martina E McMenamin et al. LANCET INFECTIOUS DISEASES
- Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections
- (2022) Heba N. Altarawneh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years of Age
- (2022) Sharon H.X. Tan et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 IgG seropositivity after the severe Omicron wave of COVID-19 in Hong Kong
- (2022) Rosana Wing-Shan Poon et al. Emerging Microbes & Infections
- Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening
- (2021) Daniel B. Larremore et al. Science Advances
- Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization
- (2021) Minal K. Patel et al. VACCINE
- Evaluation of the INDICAID COVID-19 Rapid Antigen Test in Symptomatic Populations and Asymptomatic Community Testing
- (2021) Ricky Y. T. Chiu et al. Microbiology Spectrum
- Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021
- (2021) Nathaniel M Lewis et al. JOURNAL OF INFECTIOUS DISEASES
- Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves
- (2021) Siaw S. Boon et al. JAMA Network Open
- Use of the landmark method to address immortal person-time bias in comparative effectiveness research: a simulation study
- (2016) Xiaojuan Mi et al. STATISTICS IN MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started